Characteristics | Cured n = 524 (47.4%) | Not cured n = 149 (13.5%) | Defaulted n = 250 (22.6%) | Died n = 132 (11.9%) | Otheran = 51 (4.6%) | Total N = 1106 |
---|---|---|---|---|---|---|
Demographic factors | ||||||
Women (%) | 323 (61.6) | 79 (53.0) | 128 (51.2) | 64 (48.5) | 33 (64.7) | 627 (56.7)c |
Median age, years [IQR] | 32 [27-40] | 35 [29-40] | 33 [27-40] | 34 [30-42] | 35 [27-44] | 33 [28-40]f |
Follow up in HIV care | ||||||
New patients (%) | 398 (76.0) | 116 (77.9) | 208 (83.2) | 102 (77.3) | 32 (62.8) | 856 (77.4)d |
In HIV care (%) | 126 (24.0) | 33 (22.1) | 42 (16.8) | 30 (22.7) | 19 (37.2) | 250 (22.6) |
Nutritional status a | ||||||
BMI, kg/m2, median [IQR] | 16.0 [15.4-16.5] | 15.5 [14.6-16.3] | 15.6 [14.3-16.3] | 15.2 [14.0-16.2] | 15.5 [14.3-16.4] | 15.8 [14.9-16.4]e |
Severe malnutrition, BMI <16 kg/m2 (%) | 245 (46.8) | 96 (64.4) | 157 (62.8) | 91 (68.9) | 28 (54.9) | 617 (55.8)e |
Moderate malnutrition, BMI 16-17 kg/m2 (%) | 279 (53.2) | 53 (35.6) | 93 (37.2) | 41 (31.1) | 23 (45.1) | 489 (44.2) |
Clinical & immunological factors | ||||||
Non-cumulative HIV clinical stage (%) | n = 508 | n = 143 | n = 242 | n = 128 | n = 49 | n = 1070 c |
Asymptomatic | 40 (7.9) | 10 (7.0) | 20 (8.3) | 12 (9.4) | 5 (10.2) | 87 (8.1) |
1 or 2 | 149 (29.3) | 48 (33.5) | 50 (20.7) | 21 (16.4) | 10 (20.4) | 278 (26.0) |
3 | 248 (48.8) | 65 (45.5) | 119 (49.2) | 65 (50.8) | 23 (46.9) | 520 (48.6) |
4 | 71 (14.0) | 20 (14.0) | 53 (21.8) | 30 (23.4) | 11 (22.5) | 185 (17.3) |
CD4 cell counts, cells/mm 3 | n = 411 | n = 119 | n = 155 | n = 83 | n = 38 | n = 806 e |
Median [IQR] | 122 [46-272] | 188 [86-360] | 94 [24-232] | 39 [17-126] | 74 [42-206] | 114 [37-268] |
<50 (%) | 111 (27.0) | 25 (21.0) | 61 (39.3) | 46 (55.5) | 14 (36.8) | 257 (31.9) |
50-200 (%) | 161 (39.2) | 36 (30.3) | 46 (29.7) | 24 (28.9) | 14 (36.8) | 281 (34.9) |
>200 (%) | 139 (33.8) | 58 (48.7) | 48 (31.0) | 13 (15.7) | 10 (26.4) | 268 (33.2) |
ART status (%) | ||||||
Not eligible for ART | 132 (25.2) | 56 (37.6) | 89 (35.6) | 29 (22.0) | 10 (19.6) | 316 (28.6)e |
On ART | 68 (13.0) | 17 (11.4) | 23 (9.2) | 20 (15.2) | 5 (9.8) | 133 (12.0) |
ART started at/after admission | 298 (56.8) | 70 (47.0) | 46 (18.4) | 36 (27.3) | 20 (39.2) | 470 (42.5) |
Eligible but no ART | 26 (5.0) | 6 (4.0) | 92 (36.8) | 47 (35.5) | 16 (31.4) | 187 (16.9) |
ART regimen (%) b | n = 68 | n = 17 | N = 23 | n = 20 | n = 5 | n = 133 f |
2 NRTI + 1 NNRTI | 64 (94.1) | 17 (100) | 22 (95.7) | 20 (100) | 5 (100) | 128 (96.2) |
Second-line therapy | 1 (1.5) | 0 (0.0) | 1 (4.3) | 0 (0.0) | 0 (0.0) | 2 (1.5) |
ART interrupted | 3 (4.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 3 (2.3) |